Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 385

1.

Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation.

van Leeuwen MT, Grulich AE, Webster AC, McCredie MR, Stewart JH, McDonald SP, Amin J, Kaldor JM, Chapman JR, Vajdic CM.

Blood. 2009 Jul 16;114(3):630-7. doi: 10.1182/blood-2009-02-202507.

2.

Immunosuppression and other risk factors for lip cancer after kidney transplantation.

van Leeuwen MT, Grulich AE, McDonald SP, McCredie MR, Amin J, Stewart JH, Webster AC, Chapman JR, Vajdic CM.

Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):561-9. doi: 10.1158/1055-9965.EPI-08-0919.

3.

Cutaneous melanoma is related to immune suppression in kidney transplant recipients.

Vajdic CM, van Leeuwen MT, Webster AC, McCredie MR, Stewart JH, Chapman JR, Amin J, McDonald SP, Grulich AE.

Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2297-303. doi: 10.1158/1055-9965.EPI-09-0278.

4.

Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma.

Opelz G, Daniel V, Naujokat C, Döhler B.

Transplantation. 2009 Oct 27;88(8):962-7. doi: 10.1097/TP.0b013e3181b9692d.

PMID:
19855238
5.

Risk of lymphoid neoplasia after cardiothoracic transplantation. a cohort study of the relation to Epstein-Barr virus.

Swerdlow AJ, Higgins CD, Hunt BJ, Thomas JA, Burke MM, Crawford DH, Yacoub MH.

Transplantation. 2000 Mar 15;69(5):897-904.

PMID:
10755547
6.

[Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].

Franco A, Jiménez L, Aranda I, Alvarez L, González M, Rocamora N, Olivares J.

Nefrologia. 2002;22(5):463-9. Review. Spanish.

7.

Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study.

van Leeuwen MT, Webster AC, McCredie MR, Stewart JH, McDonald SP, Amin J, Kaldor JM, Chapman JR, Vajdic CM, Grulich AE.

BMJ. 2010 Feb 11;340:c570. doi: 10.1136/bmj.c570.

8.

Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.

Polesel J, Clifford GM, Rickenbach M, Dal Maso L, Battegay M, Bouchardy C, Furrer H, Hasse B, Levi F, Probst-Hensch NM, Schmid P, Franceschi S; Swiss HIV Cohort Study..

AIDS. 2008 Jan 11;22(2):301-6.

PMID:
18097233
9.

Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphoma.

Trofe J, Buell JF, Woodle ES, Beebe TM, Hanaway MJ, First MR, Alloway RR, Gross TG.

Transplantation. 2004 Oct 15;78(7):972-7.

PMID:
15480161
10.

Hepatocellular carcinoma and non-Hodgkin's lymphoma: the roles of HIV, hepatitis C infection, and alcohol abuse.

McGinnis KA, Fultz SL, Skanderson M, Conigliaro J, Bryant K, Justice AC.

J Clin Oncol. 2006 Nov 1;24(31):5005-9.

PMID:
17075119
11.

Changing epidemiology and risk factors for gastrointestinal non-Hodgkin's lymphoma in a North American population: population-based study.

Andrews CN, John Gill M, Urbanski SJ, Stewart D, Perini R, Beck P.

Am J Gastroenterol. 2008 Jul;103(7):1762-9. doi: 10.1111/j.1572-0241.2008.01794.x.

PMID:
18557717
12.

Lymphoproliferative disease after renal transplantation in Australia and New Zealand.

Faull RJ, Hollett P, McDonald SP.

Transplantation. 2005 Jul 27;80(2):193-7.

PMID:
16041263
13.

Increasing incidence of non-Hodgkin's lymphoma in Karachi, 1995-2002.

Bhurgri Y, Pervez S, Bhurgri A, Faridi N, Usman A, Kazi LA, Ahmed R, Kayani N, Hasan SH.

Asian Pac J Cancer Prev. 2005 Jul-Sep;6(3):364-9.

14.

The epidemiology of non-Hodgkin lymphoma.

Grulich AE, Vajdic CM.

Pathology. 2005 Dec;37(6):409-19. Review.

PMID:
16373224
15.

Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low.

Farrell RJ, Ang Y, Kileen P, O'Briain DS, Kelleher D, Keeling PW, Weir DG.

Gut. 2000 Oct;47(4):514-9.

16.
17.
18.

Adipose tissue concentrations of dioxins and dibenzofurans, titers of antibodies to Epstein-Barr virus early antigen and the risk for non-Hodgkin lymphoma.

Hardell L, Lindström G, van Bavel B, Hardell K, Linde A, Carlberg M, Liljegren G.

Environ Res. 2001 Oct;87(2):99-107.

PMID:
11683593
19.

Concentrations of organohalogen compounds and titres of antibodies to Epstein-Barr virus antigens and the risk for non-Hodgkin lymphoma.

Hardell K, Carlberg M, Hardell L, Björnfoth H, Ericson Jogsten I, Eriksson M, Van Bavel B, Lindström G.

Oncol Rep. 2009 Jun;21(6):1567-76.

PMID:
19424638
20.

Tricyclic antidepressants and non-Hodgkin lymphoma.

Dalton SO, Poulsen AH, Nørgaard M, McLaughlin JK, Johansen C, Friis S.

Epidemiology. 2008 Jul;19(4):546-9. doi: 10.1097/EDE.0b013e318176bf98.

PMID:
18552589
Items per page

Supplemental Content

Support Center